세계의 단백질 발현 시장 : 제품 유형, 제품 및 서비스, 용도, 최종 사용자별 예측(2025-2030년)

The Protein Expression Market was valued at USD 3.59 billion in 2023, expected to reach USD 4.09 billion in 2024, and is projected to grow at a CAGR of 14.12%, to USD 9.07 billion by 2030.

Protein expression refers to the process by which proteins are synthesized, modified, and regulated in living organisms, serving as crucial components in cellular functions and biotechnological applications. This market is essential due to its significant role in pharmaceutical development, including the creation of therapeutics and vaccines, as well as research in biotechnology and molecular biology. Applications extend across diverse fields such as drug discovery, biopharmaceutical production, and diagnostics, with end-use industries including healthcare, biotechnology firms, and research institutions. Noteworthy growth factors in this market include advancements in technology such as cell-free protein synthesis and the increasing demand for biologics and personalized medicine. Additionally, the rising prevalence of chronic diseases further boosts the necessity for protein expression solutions in drug development. However, the market faces challenges like high costs of equipment and reagents, complex regulatory frameworks, and the technical challenges associated with protein production and purification. Opportunities in the sector involve growing investments in research and development, particularly in synthetic biology and the development of novel expression systems like CRISPR-based approaches. Companies can capitalize on these opportunities by investing in innovative research methodologies, enhancing collaboration with academic institutions, and expanding their presence in emerging markets. The competitive landscape is characterized by rapid technological innovations, which necessitate continual adaptation by firms to maintain a competitive edge. The nature of the protein expression market is dynamic, with a focus on the development of more efficient, cost-effective, and versatile expression systems. Areas ripe for innovation include bioinformatics tools for protein analysis, improvements in expression vector design, and the integration of AI and machine learning to predict protein expression outcomes. Overall, staying ahead in this fast-evolving market demands agility, strategic investments, and a focus on collaborative and forward-thinking research efforts.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Protein Expression Market

The Protein Expression Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • High prevalence of infectious & chronic diseases among geriatric population and children
  • Rising focus on personalized medicine & protein therapeutics in the consumers
  • Surging inclination of demand toward biologics and biosimilars proteins
• Market Restraints
  • Complex production and contamination risks during the development of protein expression
• Market Opportunities
  • Advancements in synthetic biology and surging investments protein development
  • Growing potential for recombinant protein in animal reproduction, feed efficiency, and health
• Market Challenges
  • High cost of protein expression reagents & instruments and significant shortage of trained healthcare professionals

Porter's Five Forces: A Strategic Tool for Navigating the Protein Expression Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Protein Expression Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Protein Expression Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Protein Expression Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Protein Expression Market

A detailed market share analysis in the Protein Expression Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Protein Expression Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Protein Expression Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Protein Expression Market

A strategic analysis of the Protein Expression Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Protein Expression Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Agilent Technologies, Inc., Artes Biotechnology GmbH, ARVYS Proteins, Inc., Bio-Rad Laboratories, Inc., Bioneer Corporation, Boster Biological Technology, BPS Bioscience, Inc., Charles River Laboratories International, Inc., Cusabio Technology LLC, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Genscript Biotech Corporation, Jena Bioscience GmbH, Jubilant Pharmova Limited, Leniobio GmbH, Lifesensors Inc., Lonza Group Ltd., Lucigen Corporation, Merck KgaA, New England Biolabs, Inc., Novoprotein Scientific Inc., Oxford Expression Technologies Ltd., Peak Proteins Ltd., Promab Biotechnologies, Inc., Promega Corporation, Proteos, Inc., Qiagen N.V., R&D Systems, Inc., RayBiotech Life, Inc., Sino Biological, Inc., Synbio Technologies, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Protein Expression Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Algal-Based Expression Systems, Cell-Free Expression Systems, Insect Cell Expression Systems, Mammalian Cell Expression Systems, Prokaryotic Expression Systems, and Yeast Expression Systems. The Insect Cell Expression Systems is further studied across Baculovirus Systems. The Mammalian Cell Expression Systems is further studied across Chinese Hamster Ovary Systems. The Prokaryotic Expression Systems is further studied across Escherichia Coli Systems. The Yeast Expression Systems is further studied across K. Lactis Systems, Pichia Systems, and Saccharomyces Systems.
• Based on Product & Service, market is studied across Competent Cells, Expression Vectors, Instruments, and Reagents.
• Based on Application, market is studied across Industrial, Research, and Therapeutic.
• Based on End-User, market is studied across Academic Research Institutes, Contract Research Organizations & Contract Manufacturing Organizations (CRO & CMO), and Pharmaceutical & Biopharmaceutical Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. High prevalence of infectious & chronic diseases among geriatric population and children
    • 5.1.1.2. Rising focus on personalized medicine & protein therapeutics in the consumers
    • 5.1.1.3. Surging inclination of demand toward biologics and biosimilars proteins
  • 5.1.2. Restraints
    • 5.1.2.1. Complex production and contamination risks during the development of protein expression
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in synthetic biology and surging investments protein development
    • 5.1.3.2. Growing potential for recombinant protein in animal reproduction, feed

efficiency, and health

• 5.1.4. Challenges
  • 5.1.4.1. High cost of protein expression reagents & instruments and significant shortage of trained healthcare professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Protein Expression Market, by Type

• 6.1. Introduction
• 6.2. Algal-Based Expression Systems
• 6.3. Cell-Free Expression Systems
• 6.4. Insect Cell Expression Systems
  • 6.4.1. Baculovirus Systems
• 6.5. Mammalian Cell Expression Systems
  • 6.5.1. Chinese Hamster Ovary Systems
• 6.6. Prokaryotic Expression Systems
  • 6.6.1. Escherichia Coli Systems
• 6.7. Yeast Expression Systems
  • 6.7.1. K. Lactis Systems
  • 6.7.2. Pichia Systems
  • 6.7.3. Saccharomyces Systems

7. Protein Expression Market, by Product & Service

• 7.1. Introduction
• 7.2. Competent Cells
• 7.3. Expression Vectors
• 7.4. Instruments
• 7.5. Reagents

8. Protein Expression Market, by Application

• 8.1. Introduction
• 8.2. Industrial
• 8.3. Research
• 8.4. Therapeutic

9. Protein Expression Market, by End-User

• 9.1. Introduction
• 9.2. Academic Research Institutes
• 9.3. Contract Research Organizations & Contract Manufacturing Organizations (CRO & CMO)
• 9.4. Pharmaceutical & Biopharmaceutical Companies

10. Americas Protein Expression Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Protein Expression Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Protein Expression Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. 10x Genomics Launches Visium CytAssist Gene and Protein Expression Assay
  • 13.3.2. Polyplus Acquires Xpress Biologics to Expand Plasmid DNA Offer
  • 13.3.3. Roche Launches PRAME (EPR20330) Antibody to Identify PRAME Protein Expression in Patients that May Have Melanoma
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abcam PLC
• 2. Agilent Technologies, Inc.
• 3. Artes Biotechnology GmbH
• 4. ARVYS Proteins, Inc.
• 5. Bio-Rad Laboratories, Inc.
• 6. Bioneer Corporation
• 7. Boster Biological Technology
• 8. BPS Bioscience, Inc.
• 9. Charles River Laboratories International, Inc.
• 10. Cusabio Technology LLC
• 11. Eurofins Scientific SE
• 12. F. Hoffmann-La Roche AG
• 13. Genscript Biotech Corporation
• 14. Jena Bioscience GmbH
• 15. Jubilant Pharmova Limited
• 16. Leniobio GmbH
• 17. Lifesensors Inc.
• 18. Lonza Group Ltd.
• 19. Lucigen Corporation
• 20. Merck KgaA
• 21. New England Biolabs, Inc.
• 22. Novoprotein Scientific Inc.
• 23. Oxford Expression Technologies Ltd.
• 24. Peak Proteins Ltd.
• 25. Promab Biotechnologies, Inc.
• 26. Promega Corporation
• 27. Proteos, Inc.
• 28. Qiagen N.V.
• 29. R&D Systems, Inc.
• 30. RayBiotech Life, Inc.
• 31. Sino Biological, Inc.
• 32. Synbio Technologies
• 33. Thermo Fisher Scientific, Inc.